Oncolix Inc. (fka ONCX)

[steadyhand]

WEBPAGE UPDATES LETS GO!


https://www.oncolixbio.com/news-and-events.html


AEPP Announces Proposed Name Change to Oncolix, Inc.
HOUSTON, TX, August 22, 2017 -- AEPP, a Houston-based biotechnology company focused on gynecological cancers, today announced it intends to change its name to Oncolix, Inc. The new name is expected to be effective after the mailing of notice to its shareholders in September. The Company also intends to adopt a new stock symbol at that time. AEPP recently acquired all of the outstanding securities of Oncolix, Inc. in a reverse merger completed on August 3, 2017.

“We are very excited about the name change as it more accurately reflects our focus as an emerging biopharmaceutical company with a clinical-stage asset”, said Michael Redman, CEO of AEPP. “This is the latest in a series of steps to re-position AEPP as a biopharmaceutical company with an exciting product portfolio.”

As Oncolix, the company expects to accelerate this transformation through the execution of key priorities and anticipated milestones, including:
Strengthening of the board of directors and
Building the clinical/scientific advisory board
Submission of Prolanta™ for Orphan Designation in the European Union
Building of drug pipeline beyond Prolanta
Uplisting to a national securities exchange
Clinical results relating to Prolanta